King's College London

Research portal

Nicotine use in schizophrenia: The self medication hypotheses

Research output: Contribution to journalLiterature review

Standard

Nicotine use in schizophrenia: The self medication hypotheses. / Kumari, V; Postma, P.

In: Neuroscience and Biobehavioral Reviews, Vol. 29, No. 6, 2005, p. 1021 - +.

Research output: Contribution to journalLiterature review

Harvard

Kumari, V & Postma, P 2005, 'Nicotine use in schizophrenia: The self medication hypotheses', Neuroscience and Biobehavioral Reviews, vol. 29, no. 6, pp. 1021 - +. https://doi.org/10.1016/j.neubiorev.2005.02.006

APA

Kumari, V., & Postma, P. (2005). Nicotine use in schizophrenia: The self medication hypotheses. Neuroscience and Biobehavioral Reviews, 29(6), 1021 - +. https://doi.org/10.1016/j.neubiorev.2005.02.006

Vancouver

Kumari V, Postma P. Nicotine use in schizophrenia: The self medication hypotheses. Neuroscience and Biobehavioral Reviews. 2005;29(6):1021 - +. https://doi.org/10.1016/j.neubiorev.2005.02.006

Author

Kumari, V ; Postma, P. / Nicotine use in schizophrenia: The self medication hypotheses. In: Neuroscience and Biobehavioral Reviews. 2005 ; Vol. 29, No. 6. pp. 1021 - +.

Bibtex Download

@article{ccbe57ee66ed43f1b514a41f7c072599,
title = "Nicotine use in schizophrenia: The self medication hypotheses",
abstract = "The behavioural and cognitive effects of nicotine in schizophrenia have received much interest in recent years. The rate of smoking in patients with schizophrenia is estimated to be two- to four-fold the rate seen in the general population. Furthermore such patients favour stronger cigarettes and may also extract more nicotine from their cigarettes than other smokers. The question has been raised whether the widespread smoking behaviour seen in this patient group is in fact a manifestation of a common underlying physiology, and that these patients smoke in an attempt to self-medicate. We present an overview of the explanations for elevated rates of smoking in schizophrenia, with particular emphasis on the theories relating this behaviour to sensory gating and cognitive deficits in this disorder that have been viewed as major support for the self-medication hypotheses. (c) 2005 Elsevier Ltd. All rights reserved",
author = "V Kumari and P Postma",
year = "2005",
doi = "10.1016/j.neubiorev.2005.02.006",
language = "English",
volume = "29",
pages = "1021 -- +",
journal = "Neuroscience and Biobehavioral Reviews",
issn = "0149-7634",
number = "6",

}

RIS (suitable for import to EndNote) Download

TY - JOUR

T1 - Nicotine use in schizophrenia: The self medication hypotheses

AU - Kumari, V

AU - Postma, P

PY - 2005

Y1 - 2005

N2 - The behavioural and cognitive effects of nicotine in schizophrenia have received much interest in recent years. The rate of smoking in patients with schizophrenia is estimated to be two- to four-fold the rate seen in the general population. Furthermore such patients favour stronger cigarettes and may also extract more nicotine from their cigarettes than other smokers. The question has been raised whether the widespread smoking behaviour seen in this patient group is in fact a manifestation of a common underlying physiology, and that these patients smoke in an attempt to self-medicate. We present an overview of the explanations for elevated rates of smoking in schizophrenia, with particular emphasis on the theories relating this behaviour to sensory gating and cognitive deficits in this disorder that have been viewed as major support for the self-medication hypotheses. (c) 2005 Elsevier Ltd. All rights reserved

AB - The behavioural and cognitive effects of nicotine in schizophrenia have received much interest in recent years. The rate of smoking in patients with schizophrenia is estimated to be two- to four-fold the rate seen in the general population. Furthermore such patients favour stronger cigarettes and may also extract more nicotine from their cigarettes than other smokers. The question has been raised whether the widespread smoking behaviour seen in this patient group is in fact a manifestation of a common underlying physiology, and that these patients smoke in an attempt to self-medicate. We present an overview of the explanations for elevated rates of smoking in schizophrenia, with particular emphasis on the theories relating this behaviour to sensory gating and cognitive deficits in this disorder that have been viewed as major support for the self-medication hypotheses. (c) 2005 Elsevier Ltd. All rights reserved

U2 - 10.1016/j.neubiorev.2005.02.006

DO - 10.1016/j.neubiorev.2005.02.006

M3 - Literature review

VL - 29

SP - 1021 - +

JO - Neuroscience and Biobehavioral Reviews

T2 - Neuroscience and Biobehavioral Reviews

JF - Neuroscience and Biobehavioral Reviews

SN - 0149-7634

IS - 6

ER -

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454